SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Romano, based in the United States, brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. She will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.
The appointment comes as SS Innovations prepares to scale its presence in the global surgical robotics market. The company’s SSi Mantra system is designed to make robotic surgery more affordable and accessible, and Romano’s experience in capital markets and financial strategy is expected to be instrumental in navigating the regulatory pathway and funding requirements. According to the full press release here, the company plans to leverage her expertise to support its expansion.
SS Innovations develops surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. As an American company headquartered in India, SS Innovations aims to expand the global presence of its cost-effective surgical robotic solutions.
The company’s forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, involve risks and uncertainties. These include factors beyond management’s control, as detailed in the company’s SEC filings. Further information is available on the InvestorBrandNetwork website here.
